SecurityUNLYF / Unilever, PLC (904784501)
Form 6-K Count198
Form CORRESP Count11
Form 424B5 Count7
Form 20-F Count7

SEC Filings - 10K, 8K, Annual Reports

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Unilever, PLC


DateFormTitle
2018-03-20 424B5 UNLYF / Unilever, PLC 424B5 (Prospectus)
2018-03-19 424B5 UNLYF / Unilever, PLC 424B5 (Prospectus)
2017-03-02 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2017-02-28 IRANNOTICE Unilever IRANNOTICE
2017-02-28 20-F Unilever 20-F
2017-02-22 6-K Unilever GUIDANCE UPDATE (Current Report of Foreign Issuer)
2017-02-22 6-K Unilever UNILEVER REVIEW (Current Report of Foreign Issuer)
2017-02-21 SC14D9C Unilever SC14D9C
2017-02-21 6-K Unilever JOINT STATEMENT FROM UNILEVER AND KRAFT HEINZ (Current Report of Foreign Issuer)
2017-02-17 SC14D9C Unilever SC14D9C
2017-02-17 6-K Unilever STATEMENT RE ANNOUNCEMENT BY KRAFT HEINZ COMPANY (Current Report of Foreign Issuer)
2017-02-10 6-K Unilever PUBLICATION OF FINAL TERMS: EUR1.2BN BONDS (Current Report of Foreign Issuer)
2017-02-08 6-K Unilever UNILEVER ISSUES EUR1.2BN BONDS ON EUROPEAN MARKETS (Current Report of Foreign Issuer)
2017-02-07 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2017-02-02 6-K Unilever PUBLICATION OF FINAL TERMS: UNILEVER GBP350M BONDS (Current Report of Foreign Issuer)
2017-01-30 6-K Unilever UNILEVER ISSUES GBP350M BONDS ON STERLING MARKET (Current Report of Foreign Issuer)
2017-01-26 6-K Unilever PUBLICATION OF A PROSPECTUS (Current Report of Foreign Issuer)
2017-01-26 6-K Unilever FULL YEAR RESULTS 2016 (Current Report of Foreign Issuer)
2016-12-13 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-11-08 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-10-13 6-K Unilever 3RD QUARTER RESULTS (Current Report of Foreign Issuer)
2016-10-05 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-09-06 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-08-08 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-07-28 6-K Unilever 6-K (Current Report of Foreign Issuer)
2016-07-27 6-K Unilever UNILEVER PRICES $1.25BN BOND ON THE U.S. MARKET (Current Report of Foreign Issuer)
2016-07-26 424B5 Unilever 424B5 (Prospectus)
2016-07-26 FWP Unilever FWP
2016-07-25 6-K Unilever 6-K (Current Report of Foreign Issuer)
2016-07-25 424B3 Unilever 424B3 (Prospectus)
2016-07-25 6-K Unilever 2ND QUARTER RESULTS 2016 (Current Report of Foreign Issuer)
2016-07-22 6-K Unilever 6-K (Current Report of Foreign Issuer)
2016-07-07 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-05-31 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-05-31 SD Unilever FORM SD
2016-05-04 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-04-27 6-K Unilever PUBLICATION OF FINAL TERMS - EUR1.5BN BONDS (Current Report of Foreign Issuer)
2016-04-25 6-K Unilever UNILEVER ISSUES EUR1.5 BILLION BONDS (Current Report of Foreign Issuer)
2016-04-22 6-K Unilever PUBLICATION OF A PROSPECTUS (Current Report of Foreign Issuer)
2016-04-21 6-K Unilever RESULT OF 2016 AGM (Current Report of Foreign Issuer)
2016-04-14 6-K Unilever 1ST QUARTER RESULTS 2016 (Current Report of Foreign Issuer)
2016-04-04 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-03-14 6-K Unilever 6-K (Current Report of Foreign Issuer)
2016-03-03 6-K Unilever BATCH FILING (Current Report of Foreign Issuer)
2016-02-24 6-K Unilever NOTIFICATION OF A CHANGE TO THE BOARDS (Current Report of Foreign Issuer)
2016-02-24 6-K Unilever PUBLICATION OF PROSPECTUS (Current Report of Foreign Issuer)
2016-02-23 IRANNOTICE Unilever Form IRANNOTICE
2016-02-23 6-K Unilever Form 6-K (Current Report of Foreign Issuer)
2016-02-23 20-F Unilever Form 20-F
2016-02-05 6-K Unilever Form 6-K (Current Report of Foreign Issuer)

Related Articles

HIMX: Himax Technologies Analysis and Research Report

15h - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

CUSIP: 904784501